We’re pleased to announce that effective immediately Ceramedix, Inc. has joined Biolabs@NYULangone as a resident company in Long Island City, New York.

Biolabs@NYULangone is part of a global network of premier coworking lab and office spaces supporting early-stage life science companies. It offers a collaborative environment with access to state-of-the-art equipment, core facilities, operational resources, and networking opportunities designed to accelerate innovation.

We’re grateful to the Biolabs team for their support and look forward to advancing our work within this dynamic ecosystem as we continue our effort to develop our proprietary therapeutics designed to address serious injury to the microvascular system; including diabetic retinal disease, gastrointestinal acute radiation syndrome, and additional potential indications with high unmet need.